Skip to content
10-Q

Quarterly Report

HypGen Inc

0001477932-17-001737

← back to feed
Filed
Apr 14, 2017 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2017 · Apr 12, 2017 5M sh
Stockholders Equity Q3 2017 · Feb 28, 2017 −$93.06K
Stockholders Equity Q3 2017 · May 31, 2016 $12.38K
Total Liabilities Q3 2017 · Feb 28, 2017 $132.02K
Total Liabilities Q3 2017 · May 31, 2016 $750
Current Assets Q3 2017 · Feb 28, 2017 $26.98K
Current Assets Q3 2017 · May 31, 2016 $465
Total Assets Q3 2017 · Feb 28, 2017 $38.96K
Total Assets Q3 2017 · May 31, 2016 $13.13K
Gross Profit Q3 2017 · Feb 28, 2017 −$147
Gross Profit Q3 2017 · Feb 28, 2017 $19.97K
Gross Profit Q3 2017 · Feb 29, 2016 $85
Gross Profit Q3 2017 · Feb 29, 2016 $6.05K
Cost Of Revenue Q3 2017 · Feb 28, 2017 $845
Cost Of Revenue Q3 2017 · Feb 28, 2017 $53.2K
Cost Of Revenue Q3 2017 · Feb 29, 2016 $13.93K
Cost Of Revenue Q3 2017 · Feb 29, 2016 $68.08K
Revenue Q3 2017 · Feb 28, 2017 $698
Revenue Q3 2017 · Feb 28, 2017 $73.17K
Revenue Q3 2017 · Feb 29, 2016 $14.02K
Revenue Q3 2017 · Feb 29, 2016 $74.13K
Operating Cash Flow Q3 2017 · Feb 29, 2016 −$4.68K
Sga Expense restated Q3 2017 · Feb 29, 2016 $1.37K
Sga Expense restated Q3 2017 · Feb 29, 2016 $10.8K
Net Income Q3 2017 · Feb 29, 2016 −$1.51K
Net Income Q3 2017 · Feb 29, 2016 −$5.44K